Oral Administration of Zataria multiflora Extract Decreases IL-17 Expression in Perennial Allergic Rhinitis

Authors

  • Alireza Ranjbar Interventional Allergology and Immunology, University of Colgan, Bonn, Germany.
  • Farahzad Jabbari Allergy research Center, Mashhad University of Medical sciences, Mashhad Iran.
  • Jalal Ghorbani Allergy research Center, Mashhad University of Medical sciences, Mashhad Iran.
  • Javad Asili Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Maryam Panahi Allergy research Center, Mashhad University of Medical sciences, Mashhad Iran.
  • Mojgan Mohamadi Allergy research Center, Mashhad University of Medical sciences, Mashhad Iran.
  • Nazila Ariaee Allergy research Center, Mashhad University of Medical sciences, Mashhad Iran.
Abstract:

Background: Rhinitis, which occurs most commonly as allergic rhinitis and affects 20% of the world&rsquo;s population, is a major health care burden causing significant morbidity. Considering the high prevalence of allergic rhinitis and anti-inflammatory effects of thyme, a favorite condiment, we performed a randomized clinical trial to determine whether thyme can relieve allergic rhinitis symptoms and affect the expression of TH17- and T-regulatory cell- (Treg) related cytokines IL-17, TGF-&beta;, FOXP3, and IL-10. Methods: Thirty patients with allergic rhinitis symptoms and positive skin prick test for common aero allergens were randomly assigned to experimental or control groups. The experimental group received thyme or Zataria multiflora (ZM) extracts and the control group received placebo for two months. Expression of IL-17, TGF-b, FOXP3, and IL-10 was evaluated in all subjects by real-time PCR before and after intervention. Results: After treatment IL-17 expression was significantly less in the ZM group than in controls (p<0.05), while TGF-&beta;, FOXP3, and IL-10, expression were not significantly changed. Conclusions: Given the significant effect of thyme in reducing symptoms of allergic rhinitis and decrease IL-17 gene expression and because allergic rhinitis is a multifactorial disease, the administration of thyme extract along with conventional treatments may benefit allergic rhinitis sufferers.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

A significant increase in expression of FOXP3 and IL-17 genes in patients with allergic rhinitis underwent accelerated rush immunotherapy

Objective(s): Allergic rhinitis (AR) is a common hypersensitivity disease worldwide. Immunotherapy has been performed as the best treatment for years. This study aimed to study the gene expression pattern of immune system cells following an accelerated rush immunotherapy protocol (ARIT) in patients with AR.Materials and Methods: Fifteen ...

full text

laratadine in perennial allergic rhinitis

ylline pharmacokinetics. Clin Pharmacol Ther 1988;43: 147. 24. Conrad KA, Nymaa DW. Effects of metoprolol and propran0101 on theopbylline elimination. Clin Pharmacol Ther 1980; 28~463-7. 25. Cusack BJ, Dawson GW, Mercer GD, Vestal RE. Cigarette smoking and theophylline metabolism: effects of cimetidine. Clin Pharmacol Ther 1985:37:330-6. 26. Richer C, Mathieu M, Bah H, et al. Theophylline kinet...

full text

Perennial allergic rhinitis and keratoconjunctivitis.

There are many studies dedicated to the allergic nose, but most of them deal with seasonal allergic rhinitis and particularly with acute experimental situations. Perennial allergic rhinitis is less well documented. When studying the allergic nose, several aspects must be taken into consideration: the genetic background of the patient, various environmental factors (antigens, air pollution, clim...

full text

Natural treatment of perennial allergic rhinitis.

Perennial allergic rhinitis is an IgE-mediated inflammatory disorder of the nasal mucosa characterized by paroxysms of sneezing, nasal congestion, pruritus, and rhinorrhea. The condition may be caused by certain environmental agents, food sensitivities, structural abnormalities, metabolic conditions, or synthetic drugs. Recent health impairment outcome studies on allergic rhinitis sufferers rev...

full text

Evaluation of SubcutaneousRush Immunotherapy Effectiveness in Perennial Allergic Rhinitis after a Year from Treatment

Introduction: Allergen immunotherapy is an effective treatment for allergic rhinitis. Conventional immunotherapy takesat least 5 to 6 months to reach the maintenance dosage; nonetheless, rush immunotherapy accelerates to reach the maintenance dose several months earlier. However, the safety and efficacy of this treatment has not been widely investigated. The objective of the present study...

full text

IL-21 administration into the nostril alleviates murine allergic rhinitis.

Type I allergic diseases such as allergic rhinitis are caused by IgE-mediated humoral immune responses, while eosinophils also fulfill important roles in the etiology of IgE-mediated allergy. IL-21 regulates growth, differentiation, and function of T, B, and NK cells, while the production of IgE is also influenced by IL-21. In this study we examined whether IL-21 is capable of controlling IgE-m...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 6  issue 2

pages  203- 207

publication date 2018-05

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023